However, despite its tremendous potential for cancer therapy, both in vitro and in vivo studies have shown that a non-negligible proportion of cancer cell lines harbor innate resistance to TRAIL, which can occur at virtually every step of the cell signaling cascade [19]. Here, TNFSF10 is linked to cancer.